MedicarePartD.guide

A non-government resource built from CMS public data

Xolair on AARP Medicare Rx Saver from UHC (S5921-351)

omalizumab

Covered, with prior authorization required.

Tier 5 (specialty tier). No quantity limit.

25%
Patient pays / month, after deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

XOLAIR 150 mg/1.2mL Injection, Solution at a preferred retail pharmacy. Other covered strengths are listed below.

Prior authRequired on all 7 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 7 covered strengths and forms
FormTierPatient pays / monthLimits
XOLAIR 150 mg/1.2mL Injection, Solution525%PA
XOLAIR PFS 75 mg/.5mL Injection, Solution525%PA
XOLAIR PFS 75 mg/.5mL Injection, Solution525%PA
XOLAIR PFS 150 mg/mL Injection, Solution525%PA
XOLAIR PFS 150 mg/mL Injection, Solution525%PA
XOLAIR 300 mg/2mL Injection, Solution525%PA
XOLAIR 300 mg/2mL Injection, Solution525%PA

Other Asthma and COPD biologics on this plan

Verify with the plan before prescribing or filling. Member services: (866)460-8854. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5921-351